Boston Trust Walden Corp lessened its position in CorVel Corp. (NASDAQ:CRVL - Free Report) by 4.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 394,963 shares of the business services provider's stock after selling 20,050 shares during the quarter. Boston Trust Walden Corp owned 0.77% of CorVel worth $29,444,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in CorVel in the second quarter valued at approximately $321,316,000. Algert Global LLC increased its position in shares of CorVel by 67.0% in the second quarter. Algert Global LLC now owns 383,419 shares of the business services provider's stock valued at $23,971,000 after acquiring an additional 153,877 shares during the period. Bank of New York Mellon Corp increased its position in shares of CorVel by 0.5% in the first quarter. Bank of New York Mellon Corp now owns 184,425 shares of the business services provider's stock valued at $10,079,000 after acquiring an additional 847 shares during the period. Principal Financial Group Inc. increased its position in shares of CorVel by 8.4% in the first quarter. Principal Financial Group Inc. now owns 179,600 shares of the business services provider's stock valued at $9,815,000 after acquiring an additional 13,938 shares during the period. Finally, Bank of America Corp DE bought a new position in shares of CorVel during the second quarter valued at about $8,073,000. Institutional investors own 51.36% of the company's stock.
CorVel Stock Performance
Shares of CRVL stock opened at $85.67 on Friday. The company has a market capitalization of $4.37 billion, a price-to-earnings ratio of 36.71 and a beta of 1.07. CorVel Corp. has a one year low of $44.83 and a one year high of $89.76. The company's 50-day moving average is $75.85 and its 200 day moving average is $62.91.
CorVel (NASDAQ:CRVL - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The business services provider reported $0.67 EPS for the quarter. CorVel had a return on equity of 30.20% and a net margin of 12.02%. The company had revenue of $267.13 million during the quarter.
Analysts Set New Price Targets
Separately, Weiss Ratings raised CorVel from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, September 1st. One research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock currently has a consensus rating of "Hold".
Read Our Latest Stock Report on CorVel
Insider Activity at CorVel
In other CorVel news, Director R. Jessup sold 4,023 shares of the stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $70.07, for a total value of $281,891.61. Following the transaction, the director directly owned 111,798 shares in the company, valued at approximately $7,833,685.86. This trade represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Jennifer Yoss sold 2,100 shares of CorVel stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $70.92, for a total value of $148,932.00. Following the transaction, the vice president owned 2,173 shares in the company, valued at $154,109.16. This trade represents a 49.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 8,947 shares of company stock worth $630,420 in the last quarter. Company insiders own 39.72% of the company's stock.
CorVel Profile
(
Free Report)
CorVel Corporation is a technology-enabled provider of workers' compensation, auto liability, liability, and health care management services. The company helps employers, insurance carriers, government agencies, and third-party administrators manage claims, control medical costs, and coordinate care.
Its services include claims administration, medical bill review, utilization and clinical review, case management, pharmacy benefit management, provider networks, and other managed-care solutions.
Featured Stories
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Corp. (NASDAQ:CRVL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CorVel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.
While CorVel currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.